文献速递心外重症与机械循环支持

VA-ECMO期间低水平溶血与非出血性卒中的关联

Hemolysis and Nonhemorrhagic Stroke During Venoarterial Extracorporeal Membrane Oxygenation.
PubMed 文献 · Ann Thorac Surg · 2019-04-10

该单中心回顾性研究纳入2012年1月至2017年9月接受VA-ECMO的成人患者150例,定义植入后48小时血浆游离血红蛋白11-50 mg/dL为低水平溶血。结果显示低水平溶血患者非出血性卒中发生率显著更高(32% vs 5%),且溶血严重程度与卒中风险递增相关,卒中患者手术死亡率更高。

要点

  • VA-ECMO期间低水平溶血(48h PFHb 11-50 mg/dL)与非出血性卒中风险独立相关。
  • 溶血程度越重,非出血性卒中风险越高,呈剂量-反应关系。
  • 发生非出血性卒中的VA-ECMO患者手术死亡率显著升高。

核心结论

  • VA-ECMO支持期间低水平溶血与后续非出血性卒中相关。

研究设计与样本

  • 单中心回顾性研究,纳入2012年1月至2017年9月接受VA-ECMO的成人患者,最终150例符合纳入标准。

主要发现

  • 相比无低水平溶血,PFHb 26-50 mg/dL组非出血性卒中风险HR 11.3(95%CI 3.6-35.1,p=0.001),PFHb 11-25 mg/dL组HR 4.4(95%CI 1.36-14.85,p=0.014)。
  • 低水平溶血组VA-ECMO植入后平均血小板体积增幅更大(0.98±1.1 fL vs 0.49±0.96 fL,p=0.03)。
  • 发生非出血性卒中的患者手术死亡率更高(83% vs 45%,调整后HR 3.1,95%CI 1.8-5.3,p<0.001)。

临床怎么用

  • VA-ECMO期间应监测48小时血浆游离血红蛋白,低水平溶血(11-50 mg/dL)即提示卒中风险升高。
  • 对存在低水平溶血的患者需加强神经系统监测与抗凝管理评估。

局限性

  • 单中心回顾性设计,样本量有限(150例),结果需多中心验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hemolysis, even at low levels, activates platelets to create a prothrombotic state and is common during mechanical circulatory support. We examined the association of low-level hemolysis (LLH) and nonhemorrhagic stroke during venoarterial extracorporeal membrane oxygenation (VA ECMO) support. METHODS: A single-center retrospective review of all adult patients placed on VA ECMO from January 2012 to September 2017 was conducted. To determine the association between LLH and nonhemorrhagic stroke, patients were categorized as those with and without LLH. LLH was defined by 48-hour plasma free hemoglobin (PFHb) of 11 to 50 mg/dL after VA ECMO implantation. RESULTS: Of 201 patients who underwent VA ECMO placement, 150 (75%) met inclusion criteria and comprised the study population. They were 55 ± 14 years of age and 50 (33%) were women. Sixty-two (41%) patients had LLH. Patients with LLH had a higher likelihood of incident nonhemorrhagic stroke during VA ECMO support (20 [32%] versus 4 [5%]; adjusted hazard ratio [HR], 7.6; 95% confidence interval [CI], 2.2 to 25.9; p = 0.001). The severity of LLH was associated with an incrementally higher likelihood of a nonhemorrhagic stroke (PFHb 26 to 50 mg/dL: HR, 11.3; 95% CI, 3.6 to 35.1; p = 0.001; PFHb 11 to 25 mg/dL: HR, 4.4; 95% CI, 1.36 to 14.85; p = 0.014) in comparison with no LLH. Those with LLH had a 2-fold greater increase in mean platelet volume after VA ECMO placement (0.98 ± 1.1 fL versus 0.49 ± 0.96 fL; p = 0.03). Patients with a nonhemorrhagic stroke had a higher operative mortality (20 [83%] versus 57 [45%]; adjusted HR, 3.1; 95% CI, 1.8 to 5.3; p < 0.001). CONCLUSIONS: Hemolysis at low levels during VA ECMO support is associated with subsequent nonhemorrhagic stroke.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Saeed O, Jakobleff WA, Forest SJ, et al. Hemolysis and Nonhemorrhagic Stroke During Venoarterial Extracorporeal Membrane Oxygenation. Ann Thorac Surg. 2019. PMID: 30980824. doi:10.1016/j.athoracsur.2019.03.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。